Corrigendum to "Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway" [Biomed. Pharmacother. 96 (2017) 884-891]

doi:10.1016/j.biopha.2023.114656

科研成果详情

题名	Corrigendum to "Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway" [Biomed. Pharmacother. 96 (2017) 884-891]
作者	Lei Zhang 1; Xiaowei He2; Ting Jin3; Gang Li4; Zhenlin Jin5
发表日期	2023-04-06
发表期刊	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 影响因子和分区
语种	英语
原始文献类型	Published Erratum
ISSN	0753-3322
EISSN	1950-6007
卷号	162
DOI	10.1016/j.biopha.2023.114656
收录类别	PUBMED
URL	查看原文
PubMed ID	37031056
TOP期刊	TOP期刊
引用统计
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/174284
专题	附属第一医院眼视光学院（生物医学工程学院）、附属眼视光医院附属第一医院_手术室
作者单位	1.Department of Infection and Liver Diseases, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China.; 2.The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China.; 3.Operating Room, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China.; 4.Department of Chemoradiation Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China. Electronic address: andrewlee0923@163.com.; 5.Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China. Electronic address: jinzhenlin-beauty@wzhospital.cn.
第一作者单位	附属第一医院
第一作者的第一单位	附属第一医院
推荐引用方式 GB/T 7714	Lei Zhang,Xiaowei He,Ting Jin,et al. Corrigendum to "Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway" [Biomed. Pharmacother. 96 (2017) 884-891][J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2023,162.
APA	Lei Zhang, Xiaowei He, Ting Jin, Gang Li, & Zhenlin Jin. (2023). Corrigendum to "Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway" [Biomed. Pharmacother. 96 (2017) 884-891]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 162.
MLA	Lei Zhang,et al."Corrigendum to "Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway" [Biomed. Pharmacother. 96 (2017) 884-891]".Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 162(2023).